000			02106 a2200541 4500
005			20250514185019.0
264		0	_c20040517
008			200405s 0 0 eng d
022			_a0755-4982
024	7		_a10.1016/s0755-4982(04)98635-6 _2doi
040			_aNLM _beng _cNLM
100	1		_aSvahn, B-M
245	0	0	_aIs it safe to treat allogeneic stem cell transplanted recipients at home during the pancytopenic phase? A pilot trial. _h[electronic resource]
260			_bPresse medicale (Paris, France : 1983) _cApr 2004
300			_a474-8 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAmbulatory Care _xstatistics & numerical data
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aBone Marrow Purging _xadverse effects
650	0	4	_aCross Infection _xepidemiology
650	0	4	_aFemale
650	0	4	_aFever of Unknown Origin _xepidemiology
650	0	4	_aFollow-Up Studies
650	0	4	_aHematologic Neoplasms _xdrug therapy
650	0	4	_aHome Care Services, Hospital-Based _xstatistics & numerical data
650	0	4	_aHumans
650	0	4	_aLength of Stay _xstatistics & numerical data
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeutropenia _xchemically induced
650	0	4	_aOpportunistic Infections _xepidemiology
650	0	4	_aOutcome and Process Assessment, Health Care _xstatistics & numerical data
650	0	4	_aPancytopenia _xchemically induced
650	0	4	_aPatient Isolation _xstatistics & numerical data
650	0	4	_aPatient Readmission _xstatistics & numerical data
650	0	4	_aPilot Projects
650	0	4	_aRisk Factors
650	0	4	_aStem Cell Transplantation
650	0	4	_aSwitzerland
700	1		_aBjurman, B
700	1		_aMyrbäck, K-E
700	1		_aAschan, J
700	1		_aRingdén, O
773	0		_tPresse medicale (Paris, France : 1983) _gvol. 33 _gno. 7 _gp. 474-8
856	4	0	_uhttps://doi.org/10.1016/s0755-4982(04)98635-6 _zAvailable from publisher's website
999			_c14816873 _d14816873